Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs
Keyword: Ischemia
Reintroduction reflects clinician input and Curium investments to support reliable, long-term U.S. supply
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your… [+5197 chars]
Read Full Story ↗
Related Content
SaaS Metrics